ARCHIVES

ACS Concludes That Laetrile Organization Is Insignificant

This article is from The Cancer Letter archive.

Vol. 17 No. 46 | November 29, 1991

Download PDF Visit The Full Archive

Related Articles

AACR Cancels $7 Million Annual Meeting, Citing Fear of SARS in Toronto

April 4, 2003

Duke Promised $11.5M For Eye, Lung Research.

March 8, 2002

Simmonds Succeeds Young As ACS President; Lame-Duck Session Unlikely To Approve Funding Bills

November 8, 2002

Senate confirms Crawford as FDA commissioner.

July 22, 2005

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

October 22, 2004

FDA Publishes Parallel Track Rules, Accelerated Drug Approval Initiative

April 25, 1992